Administration, Oral; Double-Blind Method; Endothelin-1; Female; Fingers; Humans; Male; Middle Aged; Outcome Assessment (Health Care); Pyrimidines; Scleroderma, Systemic; Skin Ulcer; Sulfonamides

Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials / Khanna, D., Denton, C.P., Merkel, P.A., Krieg, T., Le Brun, F., Marr, A., Papadakis, K., Pope, J., Matucci-Cerinic, M., Furst, D.E.. - In: JAMA. - ISSN 0098-7484. - 315:(2016), pp. 1975-88-1988. [10.1001/jama.2016.5258]

Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials

Matucci-Cerinic, Marco;
2016-01-01

Abstract

Administration, Oral; Double-Blind Method; Endothelin-1; Female; Fingers; Humans; Male; Middle Aged; Outcome Assessment (Health Care); Pyrimidines; Scleroderma, Systemic; Skin Ulcer; Sulfonamides
2016
Administration
Oral
Double-Blind Method
Endothelin-1
Female
Fingers
Humans
Male
Middle Aged
Outcome Assessment (Health Care)
Pyrimidines
Scleroderma
Systemic
Skin Ulcer
Sulfonamides
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/154210
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 116
  • ???jsp.display-item.citation.isi??? 103
social impact